|
|
||||||||



* The Hamner Institutes for Health Sciences, Research Triangle Park, NC 27709; and
Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, NC 27695
The inhalation of vanadium pentoxide (V2O5) results in bronchitis and airway fibrosis. The lung fibrotic response to V2O5 partially resolves where fibroblasts first proliferate and deposit collagen, but then undergo growth arrest and apoptosis. STAT-1 mediates fibroblast growth arrest and apoptosis. We previously reported that STAT-1 is a protective factor and mice lacking STAT-1 are more susceptible to lung fibrosis. We also reported that V2O5-induced STAT-1 phosphorylation in lung fibroblasts requires H2O2 and de novo protein synthesis. In this study, we identified IFN-β as the protein that mediates STAT-1 activation by V2O5 in normal human lung fibroblasts and identified NADPH and xanthine oxidase systems as sources of H2O2 that drive IFN-β gene expression. STAT-1 phosphorylation was decreased with neutralizing Abs to IFN-β as well as an inhibitor of JAK. V2O5 also increased transcription of an IFN-inducible and STAT-1-dependent chemokine, CXCL10. Inhibition of H2O2-generating enzyme systems NADPH oxidase by apocynin and xanthine oxidase by allopurinol individually reduced STAT-1 phosphorylation. Apocynin and allopurinol also decreased V2O5-induced IFN-β mRNA levels and CXCL10 expression. IFN-
transcription was inhibited only by allopurinol. Taken together, these data indicate that fibroblasts play a role in the innate immune response to vanadium-induced oxidative stress by synthesizing IFN-β and activating STAT-1 to cause growth arrest and increase levels of CXCL10, a potent antifibrotic factor. This mechanism is postulated to counterbalance profibrogenic mechanisms that follow V2O5 injury.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by The Long-Range Research Initiative of the American Chemistry Council and National Institutes of Health R21-ES015801-01.
2 Address correspondence and reprint requests to Dr. James C. Bonner, North Carolina State University, Raleigh, NC 27695. E-mail address: james_bonner{at}ncsu.edu
3 Abbreviations used in this paper: EGF, epidermal growth factor; PDGF, platelet-derived growth factor; DPI, diphenyliodonium chloride; SFDM, serum-free defined medium; CM-H2DCFDA, 5-(and-6)-chloromethyl-2',7'dichlorodihydrofluorescein diacetate, acetyl ester; RT, reverse transcriptase; ROS, reactive oxygen species; CTGF, connective tissue growth factor; HB-EGF, heparin-binding EGF.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |